TORONTO, June 1 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc. , a developer of medical imaging systems for the operating room, will be holding its annual meeting, hosted by Dr. Arun Menawat, President and Chief Executive Officer and Mr. Roger Deck, Chief Financial Officer.
DATE: June 7, 2006 TIME: 10:30 am, Eastern Standard Time LOCATION: The Ontario Club, Canadian Room 5th Floor, Commerce Court South 30 Wellington Street West (Northeast Corner of Bay & Wellington) Toronto, Ontario, Canada WEBCAST: A live audio webcast of the call will be available at www.novadaq.com Webcast attendees are welcome to listen to the conference in real-time or on-demand at your convenience. The webcast will be archived for 90 days. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. About Novadaq Technologies
Novadaq Technologies Inc. develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular, ophthalmic, and neurologic diseases and conditions. Novadaq’s SPY(R) Intra-operative Imaging System, commercially available worldwide, enables cardiac surgeons to visually assess coronary vasculature and bypass graft functionality during the course of open-heart bypass surgery. Novadaq’s ophthalmic product, the OPTTX(R) System, is aimed at the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD) by using the same core imaging technology that is used in the SPY System. The OPTTX System is currently being evaluated in clinical trials. Novadaq’s product for nerve visualization in prostate surgery, LUNA(TM) is being developed to enable surgeons to visualize nerve bundles during the course of radical prostatectomy in order to reduce negative outcomes including impotency. For more information, please visit the company’s website at www.novadaq.com.
Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq’s current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings; actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Novadaq Technologies Inc.
CONTACT: For further information visit our website at www.novadaq.com, orcontact: Arun Menawat, PhD, MBA, President & CEO, Novadaq TechnologiesInc., (905) 629-3822 x 202, amenawat@novadaq.com; Michael Moore, InvestorRelations, The Equicom Group, (416) 815-0700 x 241, mmoore@equicomgroup.com
